Show Summaries | Hide Summaries
Apr. 26, 2013, 1:45 PMGreatbatch (GB -4.5%) slips after its Q1 top line came up shy of estimates late yesterday as total sales dipped by 7% Y/Y. Cardiac/Neuromodulation revenue decreased -5%, Electrochem -11%, due largely to tough comps in energy and military markets, Orthopaedic +11% on implant market share gains and new product launches. | Comment!
GB vs. ETF Alternatives
Greatbatch Inc designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group.
Other News & PR